Candace Black‐Schaefer

Abbott (United States)

Papers

1

Total Citations

38

H-Index

1

About

Candace Black-Schaefer has made pivotal contributions to the field of drug discovery, specializing in high-throughput analytical chemistry and metabolic stability assays. Her work centers on automating mass spectrometry methods to accelerate the screening of drug candidates, addressing a critical bottleneck in pharmaceutical development. Her most cited paper, "Automatic mass spectrometry method development for drug discovery: application in metabolic stability assays" (2004, 38 citations), introduced a pioneering approach that leverages liquid chromatography/tandem mass spectrometry (LC/MS/MS) with fast gradients to enable rapid, sensitive, and selective metabolic screening. This innovation directly supported the demands of high-throughput organic synthesis, streamlining the evaluation of drug metabolism and pharmacokinetics. Black-Schaefer’s research has had a lasting impact on the efficiency of early-stage drug discovery, helping researchers identify promising compounds faster. Her work exemplifies the integration of automation and analytical precision, making her a notable figure in advancing practical solutions for pharmaceutical research.

Research Focus

Key Achievements

1
H-Index
1
Papers
38
Total Citations
38
Avg Citations/Paper
🏆 Most Cited Paper
Automatic mass spectrometry method development for drug discovery: application in metabolic stability assays
38 citations · 2004
📈 Most Prolific Year: 2004 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Abbott (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago